Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom-and-bust cycle? By Madison Muller and Brad Stone

Trump’s Unapologetic Emissary
35:24

Where Does Spirit Airlines Go When It Dies?
29:32

Myanmar: The War the World Forgot
42:08